Lawmakers sent CEO Elizabeth Holmes a stern letter.
A powerful Congressional committee is demanding that hobbled blood diagnostics upstart Theranos describe what steps it’s taking to comply with federal law and address inaccurate test results that were provided to customers.
In a sternly-worded letter to Theranos CEO Elizabeth Holmes dated June 30, House Energy and Commerce Committee ranking member Rep. Frank Pallone and fellow Democrats Diana DeGette and Gene Green outlined the firm’s biggest recent woes, including damning lab inspections by the FDA and the Centers for Medicare and Medicaid (CMS) finding a variety of compliance issues that posed “immediate jeopardy” to patient health.
Read Full Article »